Specialty drugs have gotten the attention of all payers, with multiple efforts underway to manage the exploding costs associated with this category. A new paper from URAC summarizes the issues…
Read More
As Medicaid enrollment continues to grow, and will likely surge in 2014, states are looking for ways to control costs. Pharmacy spending has been an area of focus and a…
Read More
A Journal of the American Medical Association article, based on work sponsored by AHRQ, reviews the off-label use of atypical antipsychotics, which are usually very expensive and have significant side…
Read More
The Pharmacy Benefit Management Institute releases its most recent survey on prescription drug benefit design and cost issues. While drug spending growth has moderated, the size of the category means…
Read More
We enter the year's home stretch with a great Potpourri, focusing on comparison friction in Part D plan shopping, a Harris poll on health-related internet use, the effect of aging…
Read More
The Food & Drug Administration releases its strategic plan for regulatory science, identifying priority areas and implementation strategies for each. How the FDA carries out its strategy over the next…
Read More
Two reports from the Agency for Healthcare Research & Quality detail the use of expensive cancer biologics for Medicare beneficiaries. As for other payers, Medicare expenditures on these compounds has…
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts